Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report [PDF]
Background Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon ...
AGOSTINELLI, Enzo +6 more
core +1 more source
Early Bilateral Cystoid Macular Oedema Secondary to Fingolimod in Multiple Sclerosis
We report a case of fingolimod-associated bilateral cystoid macular oedema in a patient with multiple sclerosis (MS). A 34-year-old female, diagnosed with MS at age of 30, developed bilateral blurred vision 5 days after initiation of fingolimod.
Lei Liu, Fiona Cuthbertson
doaj +1 more source
Fingolimod: therapeutic mechanisms and ocular adverse effects. [PDF]
Fingolimod is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). We aim to review the published literature on ocular manifestations of fingolimod therapy and their possible underlying mechanisms.
A Groves +40 more
core +1 more source
Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article [PDF]
Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for neovascular age-related macular degeneration (nAMD).
Elena Gusson +8 more
core +1 more source
Posterior Sub-Tenon Triamcinolone Injection for Chronic Macular Oedema Associated With Non-Ischemic Branch or Central Retinal Vein Occlusion [PDF]
Aims: To evaluate the effectiveness and safety of Posterior Sub-Tenon (PST) Triamcinolone Acetonide (TA) injection for persistent macular oedema associated with non-ischemic Central Retinal Vein Occlusion (CRVO) or Branch Retinal Vein Occlusion (BRVO) in
Aude Ambresin +9 more
core +1 more source
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. [PDF]
BACKGROUND: Macular oedema (MO) is the accumulation of extracellular fluid in the central retina (the macula). It may occur after cataract surgery and may give rise to poor visual outcome, with reduced visual acuity and distortion of the central vision ...
Bunce, Catey +5 more
core +2 more sources
Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitis (focus) initiative [PDF]
Topic: An international, expert-led consensus initiative to develop systematic, evidence-based recommendations for the treatment of noninfectious uveitis in the era of biologics.
Acharya, Nisha +150 more
core +4 more sources
Latanoprost and cystoid macular oedema in a pseudophake [PDF]
Editor,—Latanoprost (0.005%) is a prostaglandin F-2α analogue licensed for primary open angle glaucoma. We describe the occurrence of cystoid macular oedema in a pseudophakic patient following its use. A 50 year old pseudophakic myope (−4.50 D) was prescribed latanoprost once daily, because of raised intraocular pressure despite treatment with twice ...
D R A WARDROP, P K WISHART
openaire +1 more source
Characterization of serous retinal detachments in uveitis patients with optical coherence tomography [PDF]
To determine the prevalence of serous retinal detachments (SRD) using optical coherence tomography (OCT) in a large database of patients with uveitis from a tertiary referral setting, to describe clinical features of patients with SRD, and to ascertain ...
A Catier +14 more
core +1 more source
Pseudophakic Cystoid Macular Edema [PDF]
Cataract surgery is an efficient procedure, and is generally associated with good visual results. Nevertheless, cystoid macular edema (CME) may develop, and this can result in suboptimal postoperative vision.
Lobo, C
core +1 more source

